The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

30 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Cyclic peptide-based potent and selective SIRT1/2 dual inhibitors harboring NEBI
Jiangsu University
5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors.EBI
University of Minnesota
Novel thiourea-based sirtuin inhibitory warheads.EBI
Jiangsu University
A FRET-based assay for screening SIRT5 specific modulators.EBI
Guiyang Medical University
Inhibition of the human deacylase Sirtuin 5 by the indole GW5074.EBI
University of Bayreuth
Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.EBI
TBA
Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme.EBI
Technical University of Denmark
Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5.EBI
Sapienza University of Rome
Overview of SIRT5 as a potential therapeutic target: Structure, function and inhibitors.EBI
China Pharmaceutical University
Development of hetero-triaryls as a new chemotype for subtype-selective and potent Sirt5 inhibition.EBI
Ludwig-Maximilians University
Potent and Specific Activators for Mitochondrial Sirtuins Sirt3 and Sirt5.EBI
University of Bayreuth
Identification of 2-hydroxybenzoic acid derivatives as selective SIRT5 inhibitors.EBI
University of Michigan
Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer.EBI
Guizhou Medical University
Identification of isoform/domain-selective fragments from the selection of DNA-encoded dynamic library.EBI
The University of Hong Kong
Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates.EBI
Xihua University
Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigations.EBI
Ludwig-Maximilians University
Simultaneous Inhibition of SIRT2 Deacetylase and Defatty-Acylase Activities via a PROTAC Strategy.EBI
Cornell University
Discovery of 5-Benzylidene-2-phenyl-1,3-dioxane-4,6-diones as Highly Potent and Selective SIRT1 Inhibitors.EBI
Chinese Academy of Sciences
Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery.EBI
Xihua University
A bicyclic pentapeptide-based highly potent and selective pan-SIRT1/2/3 inhibitor harboring NEBI
Fudan University
Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity.EBI
Sichuan University
Unexpected small molecules as novel SIRT2 suicide inhibitors.EBI
Engineering Research Center For The Development and Application of Ethnic Medicine and Tcm (Ministry of Education)
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.EBI
Sichuan University
Cyclic tripeptide-based potent human SIRT7 inhibitors.EBI
Jiangsu University
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.EBI
Imperial College
Human SIRT3 tripeptidic inhibitors containing N(?)-thioacetyl-lysine.EBI
Jiangsu University
X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells.EBI
West China School of Pharmacy
The mimics of NEBI
School of Pharmacy
Potent and Selective Inhibitors of Human Sirtuin 5.EBI
Martin-Luther-University Halle-Wittenberg